Biomedical Engineering Reference
In-Depth Information
213. Ettinger AB, Argoff CE (2007) Use of antiepileptic drugs for nonepileptic conditions:
psychiatric disorders and chronic pain. Neurotherapeutics 4:75-83
214. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ,
Weinberg WA, Rush J (2000) Effect size of lithium, divalproex sodium, and carbamaze-
pine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychi-
atry 39:713-720
215. Ketter TA, Kalali AH, Weisler RH (2004) A 6-month, multicenter, open-label evaluation of
beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients
with manic or mixed episodes. J Clin Psychiatry 65:668-673
216. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999) A double-
blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I
depression. J Clin Psychiatry 60:79-88
217. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P,
Ascher JA, Paska W, Earl N, DeVeaugh-Geiss J (2003) A placebo-controlled 18-month trial
of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar
I disorder. J Clin Psychiatry 64:1013-1024
218. Hosak L, Libiger J (2002) Antiepileptic drugs in schizophrenia: a review. Eur Psychiatry
17:371-378
219. Emrich HM (1990) Studies with (Trileptal) oxcarbazepine in acute mania. Int Clin
Psychopharmacol 5:S83-S88
220. Grunze HC, Normann C, Langosch J, Schaefer M, Amann B, Sterr A, Schloesser S,
Kleindienst N, Walden J (2001) Antimanic efficacy of topiramate in 11 patients in an open
trial with an on-off-on design. J Clin Psychiatry 62:464-468
221. Kanba S, Yagi G, Kamijima K, Suzuki T, Tajima O, Otaki J, Arata E, Koshikawa H, Nibuya
M, Kinoshita N (1994) The first open study of zonisamide, a novel anticonvulsant, shows
efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry 18:707-715
222. Spina E, Perugi G (2004) Antiepileptic drugs: indications other than epilepsy. Epileptic
Disord 6:57-75
223. Izzo E, Ieraci A, Meli S, Bortolato M, Frau R, Bini V, Salvati P, Anand R (2010) Adjuvant
activity of the novel sodium channel blocker NW-3509 in combination therapy with
antipsychotics. CINP - Hong Kong World Congress.
https://www1.cinp-congress.org/
guest/IDd3044a565c0d23/ID04773c0cfb0ea3/AbstractView?ABSID
8989
224. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM,
Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pikle LW (2005) Annual
report to the nation on the status of cancer, 1975-2002, featuring population-based trends in
cancer treatment. J Natl Cancer Inst 97:1407-1427
225. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008.
CA Cancer J Clin 58:71-96
226. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
227. Vaidya KS, Welch DR (2007) Metastasis suppressors and their roles in breast carcinoma. J
Mammary Gland Biol Neoplasia 12:175-190
228. Bacac M, Stamenkovic I (2007) Metastatic cancer cell. Annu Rev Pathol 3:221-247
229. Gillet L, Roger S, Bougnoux P, Le Guennec J-Y, Besson P (2010) Beneficial effects of
omega-3 long-chain fatty acids in breast cancer and cardiovascular diseases: voltage-gated
sodium channels as a common feature? Biochimie. doi:10.1016/j.biochi.2010.02.005
230. Roger S, Potier M, Vandier C, Besson P, Le Guennec J-Y (2006) Voltage-gated sodium
channels: new targets in cancer therapy? Curr Pharm Des 12:3681-3695
231. Lang F, F
¼
oller M, Lang KS, Lang PA, Ritter M, Gulbins E, Vereninov A, Huber SM (2005)
Ion channels in cell proliferation and apoptotic cell death. J Membr Biol 205:147-157
232. Sch
€
onherr R (2005) Clinical relevance of ion channels for diagnosis and therapy of cancer. J
Membr Biol 205:175-184
233. Fiske JL, Fomin VP, Brown ML, Duncan RL, Sikes RA (2006) Voltage-sensitive ion
channels and cancer. Cancer Metastasis Rev 25:493-500
€
